Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: Tumor Sample|PROCEDURE: Serum Sample
Sponsor: Hoosier Cancer Research Network
Collaborators: United States Department of Defense|Indiana University School of Medicine|Emory University